Cargando…

Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines

High-content, image-based screens enable the identification of compounds that induce cellular responses similar to those of known drugs but through different chemical structures or targets. A central challenge in designing phenotypic screens is choosing suitable imaging biomarkers. Here we present a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jungseog, Hsu, Chien-Hsiang, Wu, Qi, Liu, Shanshan, Coster, Adam D., Posner, Bruce A., Altschuler, Steven J., Wu, Lani F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844861/
https://www.ncbi.nlm.nih.gov/pubmed/26655497
http://dx.doi.org/10.1038/nbt.3419
Descripción
Sumario:High-content, image-based screens enable the identification of compounds that induce cellular responses similar to those of known drugs but through different chemical structures or targets. A central challenge in designing phenotypic screens is choosing suitable imaging biomarkers. Here we present a method for systematically identifying optimal reporter cell lines for annotating compound libraries (ORACLs), whose phenotypic profiles most accurately classify a training set of known drugs. We generate a library of fluorescently tagged reporter cell lines, and let analytical criteria determine which among them—the ORACL—best classifies compounds into multiple, diverse drug classes. We demonstrate that an ORACL can functionally annotate large compound libraries across diverse drug classes in a single-pass screen and confirm high prediction accuracy via orthogonal, secondary validation assays. Our approach will increase the efficiency, scale and accuracy of phenotypic screens by maximizing their discriminatory power.